




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































APP&P	=	antimicrobial	prescribing	policy	and	practice	Recommendation 1: national structure
A national organization should develop the national infrastructure
to support implementation of APP&P. A national clinical
forum should be established to facilitate networking across
NHSScotland in APP&P.
Recommendation 2: NHS Board responsibility
2.1 Chief Executives of NHS Boards, who are responsible for
clinical governance, should also have an overall responsibility
for APP&P in acute hospitals within their NHS Boards. They
should ensure that a local framework is in place for the imple-
mentation of the APP&P. Management processes relating
to APP&P form part of the responsibilities of the Infection
Control Manager [Health Department Letter HDL(2005)8].
2.2 The Board is responsible for establishing systems, including
information technology (IT), for implementing key areas 2–6.
Recommendation 3: hospital structures
3.1 A lead acute hospital Doctor and Pharmacist for Antimicro-
bial Prescribing Policy and Practice in hospitals should be
identified within each NHS Board.
3.2 A multidisciplinary antimicrobial management team (AMT)
for antimicrobial prescribing should be formed. This
should include the above Lead Doctor and Pharmacist,
a microbiologist and/or infectious diseases physician, and a
senior management representative (normally the Infection
Control Manager). This team should be responsible for imple-
menting the Antimicrobial Prescribing Policy and Practice.
A model structure is described in Figure 1
3.3 All acute hospitals should have an antimicrobial policy
and formulary (see Appendix 1). A recent template for
hospital antimicrobial prescribing policies from SACAR
may be helpful.20
Recommendation 4: hospital responsibility and
accountability
4.1 Clear lines of accountability should be defined between the
Chief Executive, the Lead Clinician/Pharmacist, the Drugs and
Therapeutics Committee (DTC) and AMT.
4.2 The local AMT should maintain responsibility for anti-
microbial policy and formulary management, in response to
national guidance and local susceptibility data (see key areas 4
and 5).
4.3 The AMT should have clear responsibilities and ways of
working with the DTCs and Infection Control Committee
(Appendix 2).
4.4 All clinical practitioners have a responsibility to follow good





Specialty-based Pharmacy leads for























Figure 1. Model antimicrobial prescribing practice pathway in acute hospitals. Note: The above figure outlines a proposed pathway to monitor and influence
antimicrobial prescribingwithinahospital or healthcareorganization’s clinical governancestructure. Inparticular, themultidisciplinaryAMTshouldbea subgroupof
and report to theDTC.There should alsobea clear pathof communicationwith the InfectionControlCommitteewhere theremaybeoverlapping interests or expertise.
AnAntimicrobial Pharmacist28 should take the lead in coordinating the implementation and audit of antimicrobial practice, and as such the use of existing pharmacy
structures is essential to support th s activity; the antimicrobi l pharmacist should al o eport to the Chief Pharmacist. Local investment is likely to be required to
support the establishment of lead antimicrobial pharmacists. In some hospitals there may be specialty-based lead pharmacists who could link with ward-based
pharmacists.






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Author,	Publication	year,	Country,	Title	 Design	of	study	 Participants	 • Perceptions	and	attitudes	towards	AMS	
18.	Bannan	et	al.	(2009),	Australia	(cont)	
	






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































				n	(%)	 										n	(%)	 											n	(%)	 											n	(%)	
Hospital	departments	
Surgery	 226	(20.8)	 76	(19.4)	 150	(24.5)	 −	
Paediatrics	 196	(18.0)	 51	(13.0)	 145	(23.7)	 −	
Medicine	 191	(17.6)	 115	(29.3)	 76	(12.4)	 −	
Operating	room	nurses	 86	(7.9)	 −	 86	(14.0)	 −	
Pharmacy	department	 82	(7.5)	 −	 −	 82	(100)	
Obstetrics	and	gynaecology	 61	(5.6)	 28	(7.1)	 33	(5.4)	 −	
Orthopaedics	 60	(5.5)	 24	(6.1)	 36	(5.9)	 −	
Ophthalmology	 51	(4.7)	 24	(6.1)	 27	(4.4)	 −	
Emergency	medicine	 49	(4.5)	 22	(5.6)	 27	(4.4)	 −	
Community	health	nurses	 33	(3.0)	 −	 33	(5.4)	 −	
Family	medicine	 28	(2.6)	 28	(7.1)	 −	 −	
Anaesthesiology	 24	(2.2)	 24	(6.1)	 −	 −	
Years	of	experience	since	qualification	
<	1	year	 94	(8.6)	 2	(0.5)	 76	(12.4)	 16	(19.5)	
1	to	5	years	 460	(42.3)	 171	(43.6)	 252	(41.1)	 37	(45.1)	
6	to	10	years	 247	(22.7)	 122	(31.1)	 107	(17.5)	 18	(22)	
11	to	20	years	 204	(18.8)	 61	(15.6)	 135	(22)	 8	(9.8)	
>	20	years	 82	(7.5)	 36	(9.2)	 43	(7)	 3	(3.7)	
Age	
Median	 29	 31	 28	 29	

































































































































































































































































































































































groups	 68.210	 2	 34.105	 28.916	 <	0.001	
Within	
groups	 1278.501	 1084	 1.179	 	 	
































groups	 166.262	 2	 83.131	 37.046	 <	0.001	
Within	
groups	 2432.452	 1084	 2.244	 	 	

























1080.598	 1084	 .997	 	
	







































groups	 20.080	 2	 10.040	 10.134	 <	0.001	
Within	
groups	 1073.882	 1084	 .991	 	 	



















































groups	 119.423	 2	 59.711	 26.180	 <	0.001	
Within	
groups	 2472.423	 1084	 2.281	 	 	
































groups	 264.795	 2	 132.397	 66.319	 <	0.001	
Within	
groups	 2164.075	 1084	 1.996	 	 	

















groups	 127.993	 2	 63.996	 46.657	 <	0.001	
Within	
groups	 1486.857	 1084	 1.372	 	 	
















groups	 90.898	 2	 45.449	 27.665	 <	0.001	
Within	
groups	 1780.850	 1084	 1.643	 	 	




























































groups	 203.984	 2	 101.992	 42.799	 <	0.001	
Within	
groups	 2583.212	 1084	 2.383	 	 	

















groups	 49.999	 2	 25.000	 13.992	 <	0.001	
Within	
groups	 1936.755	 1084	 1.787	 	 	







































































































































































































































groups	 20.448	 2	 10.224	 6.067	 .002	
Within	
groups	 1826.710	 1084	 1.685	 	 	
















groups	 3.010	 2	 1.505	 .978	 .376	
Within	
groups	 1667.237	 1084	 1.538	 	 	
















groups	 3.076	 2	 1.538	 .928	 .395	
Within	
groups	 1795.930	 1084	 1.657	 	 	




















































groups	 2.406	 2	 1.203	 1.030	 .358	
Within	
groups	 1266.562	 1084	 1.168	 	 	































groups	 84.876	 2	 42.438	 22.275	 <	0.001	
Within	
groups	 2065.212	 1084	 1.905	 	 	

































groups	 39.887	 2	 19.943	 11.871	 <	0.001	
Within	
groups	 1821.046	 1084	 1.680	 	 	

















groups	 21.862	 2	 10.931	 9.857	 <	0.001	
Within	
groups	 1202.122	 1084	 1.109	 	 	






















































groups	 46.723	 2	 23.362	 12.408	 <	0.001	
Within	
groups	 2040.960	 1084	 1.883	 	 	
















groups	 28.732	 2	 14.366	 8.361	 <	0.001	
Within	
groups	 1862.604	 1084	 1.718	 	 	











































































































































(N=82)	 		X2*	 df	 p	
n	(%)	 n	(%)	 n	(%)	 n	(%)	
Less	than	10%		 94	(8.6)	 13	(3.3)	 80	(13.1)	 1	(1.2)	
		15.53	 2	 		<	0.001	10	to	25%		 398	(36.6)	 171	(43.6)	 209	(34.1)	 18	(22.0)	
26	to	50%		 445	(40.9)	 164	(41.8)	 232	(37.8)	 49	(59.8)	



















(N=82)	 X2*	 df	 p	
n	(%)	 n	(%)	 n	(%)	 n	(%)	
Less	than	10%		 201	(18.5)	 67	(17.1)	 124	(20.2)	 10	(12.2)	
5.89	 2	 0.053	10	to	25%		 455	(41.9)	 168	(42.9)	 254	(41.4)	 33	(40.2)	
26	to	50%		 328	(30.2)	 114	(29.1)	 188	(30.7)	 26	(31.7)	






































































n	(%)	 n	(%)	 n	(%)	 n	(%)	

























Others	 16	(1.5)	 7	(1.8)	 8	(1.3)	 1	(1.2)	


























































n	(%)	 n	(%)	 n	(%)	 n	(%)	
Minimal	 32	(2.9)	 5	(1.3)	 25	(4.1)	 2	(2.4)	
104.314	 2	 <	0.001	
Limited	 244	(22.4)	 39	(9.9)	 191	(31.2)	 14	(17.1)	
Average	 695	(63.9)	 274	(69.9)	 368	(60.0)	 53	(64.6)	
Good	 110	(10.1)	 69	(17.6)	 28	(4.6)	 13	(15.9)	






































(N=82)	 X2*	 df	 p	













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































	 n	 %	 Median	 Q1-Q3	
Demographics	 	 	 	 	
• Gender	 	 	 	 	
o Female	 110	 53.7	 	 	
o Male	 95	 46.3	 	 	
• Age	 	 	 56	 46-65	
• Education	level	 	 	 	 	
o None	 3	 1.5	 	 	
o Primary	school	 87	 42.4	 	 	
o High	school	 46	 22.4	 	 	
o Bachelor	degree	 60	 29.3	 	 	
o Post	graduate		 9	 4.4	 	 	
• One	or	more	chronic	
diseases		

















o None	 62	 30.2	
o 1	 97	 47.3	
o 2	 22	 10.7	
o 3	 11	 5.4	
o 4	 3	 1.5	
o 5	 6	 2.9	
o 10	 4	 2.0	
• Why	did	you	take	antibiotics?	*	 	 	
o Cold	 82	 40.0	
o Wound	infection	 63	 30.7	
o Respiratory	tract	infections	 51	 24.9	
o Gastroenteritis	 19	 9.3	

































54	(26.3%)	 105	(51.2%)	 39	(19.0%)	 7	(3.4%)	
5.	I	stop	taking	antibiotics	when	I	
feel	better.	
77	(37.6%)	 65	(31.7%)	 39	(19.0%)	 24	(11.7%)	














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Clinician	questionnaire	 10Aug15		 	 	1	
Demographic information 
Profession   




☐ Male                    ☐ Female                                         ☐Other 
 
Age………….. 
Number of years qualified 
☐ <1 year       ☐ 1 to 5 years       ☐ 6 to 10 years       ☐ 11 to 20 year        ☐ >20 year  
Please indicate how serious a problem you believe antimicrobial 
resistance is in the following places (scale of 1 to 7) 
1. Antimicrobial resistance is a worldwide problem.  
☐ 1 Not a         ☐ 2              ☐ 3              ☐ 4              ☐ 5              ☐ 6             ☐7     Very 
problem                                                                                                                 serious  
                                                                                                                            problem 
2. Antimicrobial resistance is problem in Thai Community.  
☐ 1 Not a         ☐ 2              ☐ 3              ☐ 4              ☐ 5              ☐ 6             ☐7     Very 
problem                                                                                                                 serious  
                                                                                                                            problem 
3. Antimicrobial resistance is problem in Thai Hospitals.  
☐ 1 Not a         ☐ 2              ☐ 3              ☐ 4              ☐ 5              ☐ 6             ☐7     Very 
problem                                                                                                                 serious  
                                                                                                                            problem 
4. Antimicrobial resistance is a problem in the study hospital 
☐ 1 Not a         ☐ 2              ☐ 3              ☐ 4              ☐ 5              ☐ 6             ☐7     Very 
problem                                                                                                                 serious  
                                                                                                                            problem 
Please indicate how strongly you believe the following contribute to 
antimicrobial resistance at the study hospital 
5. Use of antimicrobials in Thai animal/agricultural sectors 
☐ 1 Does         ☐ 2              ☐ 3              ☐ 4              ☐ 5              ☐ 6            ☐7 Strongly    
not contribute                                                                                                 contributes  
6. Use of antimicrobials in the Thai community 
☐ 1 Does         ☐ 2              ☐ 3              ☐ 4              ☐ 5              ☐ 6            ☐7 Strongly    
not contribute                                                                                                 contributes 
7. Use of antimicrobials in Thai Hospitals  
☐ 1 Does         ☐ 2              ☐ 3              ☐ 4              ☐ 5              ☐ 6            ☐7 Strongly    
not contribute                                                                                                 contributes 
8. Use of antimicrobials at the study hospital  
☐ 1 Does         ☐ 2              ☐ 3              ☐ 4              ☐ 5              ☐ 6            ☐7 Strongly    
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Please indicate how strongly you believe the following contribute to 
antimicrobial resistance at study hospital 
9. Patient pressure for antibiotics as part of treatment 
 1 Does          2               3               4               5               6            7 
Strongly    
not contribute                                                                                                 contributes 
10. Patients are able to buy antibiotics over the counter 
 1 Does          2               3               4               5               6            7 
Strongly    
not contribute                                                                                                 contributes 
Please indicate how strongly you agree or disagree with the following 
statements  
11. I previously involved in care of patients with an antibiotic resistant infection 
 Yes                               No               Unsure 
12. I have noticed increasing number of antimicrobial resistance infections over past 5 
years 
 Yes                               No               Unsure 
13. I would estimate that the percentage of inpatient antimicrobial orders that are 
inappropriate at the study hospital is: 
 <10% year                     10 to 25%                     26 to 50%                    
>50% 
14. In which patient groups do you believe that antimicrobial orders are inappropriate at 
study hospital in order of frequency (Please number the following in order of importance 
where 1 is most importance and 5 is least) 
 Patients with community acquired infection 
 Patients with immune suppressive condition  
 Surgical patients (exclude surgical prophylaxis) 
 Patients being treatment in critical care 
 Patients being treatment in general wards 
 Patients being treatment in VIP wards 
15. I would estimate that the percentage of surgical prophylaxis orders that are 
inappropriate at the study hospital is:  
 <10% year                     10 to 25%                     26 to 50%                    
>50% 
16. What do you consider is the most frequent problem associated with surgical 
prophylaxis at the study hospital (Please tick one only) 
 Timing of first dose of prophylaxis 
 Inappropriate antibiotic chosen 
 Prophylaxis is not stopped at the appropriate time 




Clinician	questionnaire	 10Aug15		 	 	3	
Please indicate how strongly you agree or disagree with the following 
statements 
17. Improving antimicrobial prescribing at the study hospital will help decrease 
antimicrobial resistance. 
 1 Strongly         2               3             4             5             6       7 Strongly      
       disagree                                                                                                             agree 
18. Improving antimicrobial prescribing should be an organisational priority. 
 1 Strongly         2               3             4             5             6       7 Strongly      
       disagree                                                                                                             agree 
19. A formal policy for the use of antimicrobials should be introduced at study hospital. 
 1 Strongly         2               3             4             5             6       7 Strongly      
       disagree                                                                                                             agree 
20. A policy that limits the prescribing of selected antimicrobials to certain clinical 
indications via an approval process should be introduced at the study hospital. 
 1 Strongly         2               3             4             5             6       7 Strongly      
       disagree                                                                                                             agree 
21. Local antimicrobial guidelines and protocols should be introduced at the study 
hospital. 
 1 Strongly         2               3             4             5             6       7 Strongly      
       disagree                                                                                                             agree 
22. A computer application which gives advice on selection and duration of 
antimicrobial therapy for specific clinical conditions would be clinically useful 
 1 Strongly         2               3             4             5             6       7 Strongly      
       disagree                                                                                                             agree 
23. A team consisting of an ID specialist physician and Pharmacist providing 
individualized antimicrobial prescribing advice and feedback would assist with 
antimicrobial selection. 
 1 Strongly         2               3             4             5             6       7 Strongly      
       disagree                                                                                                             agree 
24. I have heard of the term “Antimicrobial stewardship”. 
 Yes                               No               Unsure 
25. I worked in healthcare facilities with AMS programs 
 Yes                               No               Unsure 
26. I would rate the level of my knowledge about appropriate antibiotic is: 
 1 Strongly         2               3             4             5             6       7 Strongly      
       disagree                                                                                                             agree 
27. I would be interested in participating in education session about AMS 
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Please indicate how strongly you agree or disagree with the following 
statements 
28. I would be willing to participate in any activities to improve the quality of 
antimicrobial use at the study hospital. 
☐ 1 Strongly        ☐ 2              ☐ 3            ☐ 4            ☐ 5            ☐ 6           ☐ 7 Strongly      
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TO: Healthcare administrators   
 
Plain Language Statement  
Date: 8 July, 2015 
Version 2 
Full Project Title: The Role of Nurses in Antimicrobial Stewardship: A Thai Case Study 
Principal Researcher:  Professor Mari Botti 
Student Researcher:  Miss Nantanit Sutthiruk 
Associate Researchers:  Professor Julie Considine   
           Associate Professor Andrea Driscoll 
    Assistant Professor Kumthorn Malathum  
 
You are invited to participate in this research project because we would like to obtain your 
views in relation to clinical governance for antimicrobial stewardship (AMS) within the Thai 
context. 
1. Your Consent 
This Plain Language Statement contains detailed information about the research project. Its 
purpose is to explain to you as openly and clearly as possible all the procedures involved in 
this project so that you can make a fully informed decision whether you wish to participate. 
Once you understand what the project is about and if you agree to take part in it, you will be 
asked to sign the Consent Form. By signing the Consent Form, you indicate that you 
understand the information and that you give your consent to participate in the research 
project. You will be given a copy of the Plain Language Statement and Consent Form to keep 
as a record. 
2. Purpose and Background 
The overall aim of this project is to explore the current and potential role of nurses in AMS in 
acute healthcare in Thailand. The specific aim of this phase is to describe the current clinical 
governance structures in your hospital that relate to AMS and how nurses are involved in 
these structures. Detailed analysis of health service clinical governance for AMS is important 
to identify alignment with international best practice, gaps in best practice and where nurses 
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3. Procedures 
You are invited to take part in a face-to-face interview. If you agree, the interview will be 
audiotaped and will take approximately 20-30 minutes using an interview guide. The 
interview will take place at a time and location that best suits you. The sorts of questions that 
will be asked include:  
• What is the current structure of antimicrobial stewardship governance at Ramathibodi 
hospital? 
• What is the main purpose of antimicrobial stewardship governance? 
• What are nurses’ current roles in antimicrobial stewardship governance at 
Ramathibodi hospital? 
• Are there roles that nurses could play in antimicrobial stewardship governance at 
Ramathibodi hospital but currently do not? Why not?  
4. Possible Benefits 
There may not be immediate benefits to you. However, your views will make a valuable 
contribution to the understanding of AMS governance in the Thai healthcare context.  
5. Possible Risks 
We do not anticipate there will be any risk to you in participating in this project.  
6. Privacy, Confidentiality and Disclosure of Information 
The information obtained in connection with the research project will be kept confidential and 
will only be used for the purpose of the research project. It will only be disclosed with your 
consent. In any publication, information will be provided in such a way that you cannot be 
identified. The data will be held in secure storage for five years after publication of the 
findings of the research project, after which it will be destroyed. 
7. Results of Project 
The results of this project will be reported as summary findings in publications and in a 
doctoral thesis.  In addition, a report of the findings will be submitted to the hospital 
executive. Should you wish to access this report, you can request it by contacting the research 
team or the Director of Ramathibodi hospital.  
8. Participation is Voluntary  
Participation in this study is voluntary. If you do not wish to take part in this study or change 
your mind after signing the consent form, you will be free to withdraw from the study without 
affecting your relationship with Ramathibodi Hospital or Deakin University. However, you 
will only be able to withdraw data within four weeks after the interview. After this time, your 
responses will have been integrated with those of others and it will not be possible to 
withdraw your data. 
9. Reimbursement for your costs 
You will not be paid for your participation in this study. 
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This project will be carried out according to the National Statement on Ethical Conduct in 
Human Research (2007) produced by the National Health and Medical Research Council of 
Australia. This statement has been developed to protect the interests of people who agree to 
participate in human research studies. The ethical aspects of this research project have been 
approved by the Human Research Ethics Committees of Deakin University and Ramathibodi 
Hospital.  
11. Complaints 
If you have any complaints about any aspect of the project, the way it is being conducted or 
any questions about your rights as a research participant, then you may contact:   
The Manager, Ethics and Biosafety, Deakin University, 221 Burwood Highway, Burwood 
Victoria 3125, Telephone: +61 03 9251 7129, or email - research-ethics@deakin.edu.au 
Please quote project number 2015-131.  
Or, The Chair of the Ethics Committee, Ramathibodi Hospital, 270, Rama VI Rd. 
Payathai, Rachathewi, Bangkok, 10400, Telephone: +66 2201 1544 
12. Further information, Queries or Any Problems 
If you require further information, wish to withdraw your participation or if you have any 
questions concerning this project, please contact: 
Nantanit Sutthiruk (Student Researcher) International phone: +61 3 9244 6319, Thailand 
phone: +66 2441 4234, Email: nsutthir@deakin.edu.au or 


























TO:  Healthcare administrators   
 
Consent Form 
Date: 8 July, 2015 
Version 2 




I have read and understand the attached Plain Language Statement. I freely agree to 
participate in this project according to the conditions in the Plain Language Statement. I have 
been given a copy of the Plain Language Statement and Consent Form to keep.  
I understand that the interview will be audio-taped and transcribed. 
The researcher has agreed not to reveal my identity and personal details, including when 
information about this project is published, or presented in any public forum.   
 
 
Participant’s Name (printed) …………………………………………………………………… 
Signature ………………………………………………………Date  ………………………… 
 
Researcher’s Name (printed) …………………………………………………………………. 















TO:  Healthcare administrators   
 
 
Withdrawal of Consent Form 
(To be used for participants who wish to withdraw from the project) 
Date:  8 July, 2015 
Version: 2 




I hereby wish to WITHDRAW my consent to participate in the above research project and 




Participant’s Name (printed)…………………………………………………………………. 
 
 




Please mail this form to: 
 
Nantanit Sutthiruk 
Ramathibodi School of Nursing, 999, Salaya, Puthamontol, Nakhonpathom, 73170, Thailand 
















TO: Doctors, nurses and pharmacists   
 
Plain Language Statement  
Date: 8 July, 2015 
Version 2 
Full Project Title: The Role of Nurses in Antimicrobial Stewardship: A Thai Case Study 
Principal Researcher:  Professor Mari Botti 
Student Researcher:  Miss Nantanit Sutthiruk 
Associate Researchers:  Professor Julie Considine   
           Associate Professor Andrea Driscoll 
    Assistant Professor Kumthorn Malathum  
 
You are invited to participate in this research project because we would like to obtain your 
perceptions and attitudes towards antimicrobial resistance, antimicrobial use and 
antimicrobial stewardship (AMS) interventions within the Thai context.  
1. Your Consent 
This Plain Language Statement contains detailed information about the research project. Its 
purpose is to explain to you as openly and clearly as possible all the procedures involved in 
this project so that you can make a fully informed decision whether you wish to participate. 
Once you understand what the project is about and if you agree to take part in it, you will be 
asked to complete a survey. By completing and returning the survey, you indicate that you 
understand the information and that you give your consent to participate in the research 
project. You may keep this copy of the Plain Language Statement as a record of your 
participation. 
2. Purpose and Background 
The overall aim of this project is to explore the current and potential role of nurses in AMS in 
acute healthcare in Thailand. The specific aim of this phase is to determine the perceptions 
and attitudes towards AMS among Thai clinicians. It is useful to understand the differences 
and similarities between professions along with barriers and facilitators to effective AMS in 
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3. Procedures 
If you consent to participate, you are invited to take part in a survey by filling out a 
questionnaire. The questionnaire contains questions about you generally (profession, 
department, gender, age, for example) and perceptions and attitudes towards antimicrobial 
resistance, antimicrobial use and AMS interventions. The expected time to complete the 
survey is approximately 10-15 minutes. 
4. Possible Benefits 
There may not be immediate benefits to you. However, your views will make a valuable 
contribution to the understanding of AMS governance in the Thai healthcare context.  
5. Possible Risks 
We do not anticipate there will be any risk to you in participating in this project.  
6. Privacy, Confidentiality and Disclosure of Information 
The information obtained from you in connection with the research project will be kept 
confidential and will only be used for the purpose of the research project. In any publication, 
information will be provided in such a way that individual responses cannot identified. The 
data will be held in secure storage for five years after publication of the research project, after 
which it will be destroyed. 
7. Result of Project 
The results of this project will be reported as summary findings in publications and in a 
doctoral thesis.  In addition a report of the findings will be submitted to the hospital executive. 
Should you wish to access this report, you can request it by contacting the research team or 
the Director of Ramathibodi hospital.  
8.Paricipation is Voluntary  
Participation in this study is voluntary. If you do not wish to take part in this study you do not 
have to do so without affecting your relationship with Ramathibodi Hospital or Deakin 
University.  
9. Reimbursement for your costs 
You will not be paid for your participation in this study. 
10. Ethical Guidelines 
This project will be carried out according to the National Statement on Ethical Conduct in 
Human Research (2007) produced by the National Health and Medical Research Council of 
Australia. This statement has been developed to protect the interests of people who agree to 
participate in human research studies. The ethical aspects of this research project have been 
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11. Complaints 
If you have any complaints about any aspect of the project, the way it is being conducted or 
any questions about your rights as a research participant, then you may contact:   
The Manager, Ethics and Biosafety, Deakin University, 221 Burwood Highway, Burwood 
Victoria 3125, Telephone: +61 03 9251 7129, research-ethics@deakin.edu.au. Please quote 
project number 2015-131. 
Or, The Chair of the Ethics Committee, Ramathibodi Hospital, 270, Rama VI Rd. 
Payathai, Rachathewi, Bangkok, 10400, Telephone: +66 2201 1544 
12. Further information, Queries or Any Problems 
If you require further information, wish to withdraw your participation or if you have any 
questions concerning this project, please contact: 
Nantanit Sutthiruk (Student Researcher) International phone: +61 3 9244 6319, Thailand 
phone: +66 2441 4234, Email: nsutthir@deakin.edu.au or 













TO: Nurses    
 
Plain Language Statement  
Date: 8 July, 2015 
Version 2 
Full Project Title: The Role of Nurses in Antimicrobial Stewardship: A Thai Case Study 
Principal Researcher:  Professor Mari Botti 
Student Researcher:  Miss Nantanit Sutthiruk 
Associate Researchers:  Professor Julie Considine   
           Associate Professor Andrea Driscoll 
    Assistant Professor Kumthorn Malathum  
 
You are invited to participate in this research project because we would like to obtain your 
views in relation to nurses’ role in AMS within the Thai context.  
1. Your Consent 
This Plain Language Statement contains detailed information about the research project. Its 
purpose is to explain to you as openly and clearly as possible all the procedures involved in 
this project so that you can make a fully informed decision whether you wish to participate. 
Once you understand what the project is about and if you agree to take part in it, you will be 
asked to sign the Consent Form. By signing the Consent Form, you indicate that you 
understand the information and that you give your consent to participate in the research 
project. You will be given a copy of the Plain Language Statement and Consent Form to keep 
as a record. 
2. Purpose and Background 
The aim of this project is to explore the current and potential role of nurses in antimicrobial 
stewardship (AMS) from patient admission, during hospitalization, and after discharge in 
acute healthcare in Thailand. Understanding the current and potential role of nurses in AMS 
is important because it will inform nursing education and professional development in relation 
to AMS, health service AMS governance, and strategies to engage patients both within the 
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You are invited to take part in a focus group. If you agree, you will be asked to complete this 
written consent form before starting the focus group. The researcher will conduct the focus 
groups while an observer documents interactions and non-verbal behaviors during the focus 
group. You will be provided with an opportunity to debrief and provide feedback. Two types 
of recording methods will be used including written notes and audio recording. The focus 
groups will be conducted over approximately 40-60 minutes using a question guide. The sorts 
of questions that will be asked include:  
• What do your understanding of antimicrobial stewardship? 
• What are the current roles for nurses/infection control nurses in antimicrobial 
stewardship? 
• What do you think potential roles for nurses/infection control nurses in antimicrobial 
stewardship may be in the future? 
• How do nurses interact with patients regarding to antimicrobial stewardship, from 
admission, during their hospitalized and in preparation for discharge? 
• What roles could nurses play to reduce antimicrobial resistance in relation to patient’s 
used of antibiotics? 
• What do you think are the barriers to nurses’ engagement in antimicrobial 
stewardship? 
4. Possible Benefits 
There may not be immediate benefits to you. However, your views will make a valuable 
contribution to nursing education and professional development in relation to AMS, health 
service AMS governance, and strategies to engage patients both within the hospital and the 
community. 
5. Possible Risks 
We do not anticipate there will be any risk to you in participating in this project.  
6. Privacy, Confidentiality and Disclosure of Information 
The information obtained in connection with the research project will be kept confidential and 
will only be used for the purpose of the research project. It will only be disclosed with your 
consent. In any publication, information will be provided in such a way that you cannot be 
identified. The data will be held in secure storage for five years after publication of the 
research project, after which it will be destroyed. 
7. Result of Project 
The results of this project will be reported as summary findings in publications and in a 
doctoral thesis.  In addition a report of the findings will be submitted to the hospital executive. 
Should you wish to access this report, you can request it by contacting the research team or 
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Participation in this study is voluntary. If you do not wish to take part, you do not have to. If 
you decided to take part and later change your mind, you are free to withdraw from this 
project at any stage before or during the focus group by informing the researcher. After the 
focus group, it will not be possible to remove information that you provided because your 
responses will have been integrated with those of others.  
9. Reimbursement for your costs 
You will not be paid for your participation in this study. 
10. Ethical Guidelines 
This project will be carried out according to the National Statement on Ethical Conduct in 
Human Research (2007) produced by the National Health and Medical Research Council of 
Australia. This statement has been developed to protect the interests of people who agree to 
participate in human research studies. The ethical aspects of this research project have been 
approved by the Human Research Ethics Committees of Deakin University and Ramathibodi 
Hospital.  
11. Complaints 
If you have any complaints about any aspect of the project, the way it is being conducted or 
any questions about your rights as a research participant, then you may contact:   
The Manager, Ethics and Biosafety, Deakin University, 221 Burwood Highway, Burwood 
Victoria 3125, Telephone: +61 03 9251 7129, research-ethics@deakin.edu.au. Please quote 
project number 2015-131. 
Or, The Chair of the Ethics Committee, Ramathibodi Hospital, 270, Rama VI Rd. 
Payathai, Rachathewi, Bangkok, 10400, Telephone: +66 2201 1544 
12. Further information, Queries or Any Problems 
If you require further information, wish to withdraw your participation or if you have any 
questions concerning this project, please contact: 
Nantanit Sutthiruk (Student Researcher) International phone: +61 3 9244 6319, Thailand 
phone: +66 2441 4234, Email: nsutthir@deakin.edu.au or 


















TO:  Nurses   
 
Consent Form 
Date: 8 July, 2015 
Version 2 




I have read and understand the attached Plain Language Statement. I freely agree to 
participate in this project according to the conditions in the Plain Language Statement. I have 
been given a copy of the Plain Language Statement and Consent Form to keep.  
I understand that the focus group will be audio-taped and transcribed. 
The researcher has agreed not to reveal my identity and personal details, including when 
information about this project is published, or presented in any public forum.   
 
 
Participant’s Name (printed) …………………………………………………………………… 
Signature ………………………………………………………Date  ………………………… 
 
Researcher’s Name (printed) ………………………………………………………………….. 


















TO:  Nurses 
 
 
Withdrawal of Consent Form 
(To be used for participants who wish to withdraw from the project) 
Date: 8 July, 2015 
Version: 2 




I hereby wish to WITHDRAW my consent to participate in the above research project and 




Participant’s Name (printed)…………………………………………………………………. 
 
 




Please mail this form to: 
 
Nantanit Sutthiruk 
Ramathibodi School of Nursing, 999, Salaya, Puthamontol, Nakhonpathom, 73170, Thailand 











TO: Patients   
 
Plain Language Statement  
Date: 8 July, 2015 
Version 2 
Full Project Title: The Role of Nurses in Antimicrobial Stewardship: A Thai Case Study 
Principal Researcher:  Professor Mari Botti 
Student Researcher:  Miss Nantanit Sutthiruk 
Associate Researchers:  Professor Julie Considine   
           Associate Professor Andrea Driscoll 
    Assistant Professor Kumthorn Malathum  
 
You are invited to participate in a research project that is being conducted by a research team 
from the School of Nursing and Midwifery, Deakin University, Australia and Ramathibodi 
Hospital. 
1. Your Consent 
This Plain Language Statement contains detailed information about the research project. Its 
purpose is to explain to you as openly and clearly as possible all the procedures involved in 
this project so that you can make a fully informed decision whether you wish to participate. 
Once you understand what the project is about you will be asked to complete a questionnaire.  
By completing and returning the questionnaire, you indicate that you understand the 
information and that you give your consent to participate in the research project. You may 
keep this Plain Language Statement as a record. 
2. Purpose and Background 
The overall aim of this project is to explore ways that nurses can participate in the safe use of 
antimicrobial medicines in acute healthcare in Thailand. Antimicrobial medicines are 
medicines used to treat or prevent infection. One of the ways that nurses can play a part in the 
safe use of antimicrobial medicines is through patient education. We wish to explore your 
attitudes and behaviors regarding your use of antimicrobial medicines (such as antibiotics) so 
that we can plan such education programs for patients and families including the development 
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3. Procedures 
If you consent to participate, you will be invited to take part in a survey by filling out a 
questionnaire. The survey contains questions about you generally (gender, age, education 
background, for example) and your thoughts and behaviors related to antimicrobial use. You 
will complete the survey by yourself; the expected time to complete the survey is 
approximately 15 minutes. 
4. Possible Benefits 
There may not be immediate benefits to you. However, your views will make a valuable 
contribution to for the way doctors and nurses provide information to patients and families.  
5. Possible Risks 
We do not anticipate there will be any risk to you in participating in this project.  
6. Privacy, Confidentiality and Disclosure of Information 
The information obtained in connection with the research project will be kept confidential and 
will only be used for the purpose of the research project. In any publication, group 
information will be reported so that individual responses cannot be identified. The data will 
be held in secure storage for five years after publication of the research project, after which it 
will be destroyed. 
7. Result of Project 
The results of this project will be reported as summary findings in publications and in a 
doctoral thesis.  In addition a report of the findings will be submitted to the hospital executive. 
Should you wish to access this report, you can request it by contacting the research team or 
the Director of Ramathibodi hospital.  
8.Paricipation is Voluntary  
Participation in this study is voluntary. If you do not wish to take part in this study, you do not 
have to do so and this will not affect your treatment or your relationship with Ramathibodi 
hospital. 
9. Reimbursement for your costs 
You will not be paid for your participation in this study. 
10. Ethical Guidelines 
This project will be carried out according to the National Statement on Ethical Conduct in 
Human Research (2007) produced by the National Health and Medical Research Council of 
Australia. This statement has been developed to protect the interests of people who agree to 
participate in human research studies. The ethics aspects of this research project have been 
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11. Complaints 
If you have any complaints about any aspect of the project, the way it is being conducted or 
any questions about your rights as a research participant, then you may contact:   
The Manager, Ethics and Biosafety, Deakin University, 221 Burwood Highway, Burwood 
Victoria 3125, Telephone: +61 03 9251 7129, research-ethics@deakin.edu.au. Please quote 
project number 2015-131. 
Or, The Chair of the Ethics Committee, Ramathibodi Hospital, 270, Rama VI Rd. 
Payathai, Rachathewi, Bangkok, 10400, Telephone: +66 2201 1544 
12. Further information, Queries or Any Problems 
If you require further information, wish to withdraw your participation or if you have any 
questions concerning this project, please contact: 
Nantanit Sutthiruk (Student Researcher) International phone: +61 3 9244 6319, Thailand 
phone: +66 2441 4234, Email: nsutthir@deakin.edu.au or 
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Background: Effective hospital-wide antimicrobial stewardship (AMS) programs need multidisci-
plinary engagement; however, clinicians’ attitudes have not been investigated in Thailand where AMS is
in early development. The aim of this study was to explore Thai clinicians’ (doctors, nurses, and phar-
macists) perceptions and attitudes toward AMS.
Methods: A paper-based survey was distributed in a 1,000-bed university hospital in Bangkok, Thai-
land, between November 9, 2015, and December 21, 2015. A total of 1,087 clinicians participated:
392 doctors, 613 nurses, and 82 pharmacists.
Results: Most participants agreed that improving antimicrobial prescribing would decrease antimicro-
bial resistance (AMR) and should be a priority of hospital policy. Doctors were less likely to agree with
policies that limit antimicrobial prescribing (P < .001) than nurses or pharmacists, and were less likely
to be interested in participating in AMS education than other clinicians (P < .001). Pharmacists indicated
higher agreement with the statement, recommending that a specialist team provide individualized an-
timicrobial prescribing advice (P < .01) and that feedback improves antimicrobial selection (P < .001). Nurses
were less likely to agree that community antibiotic use (P < .001) or patient pressure for antibiotics con-
tribute to AMR (P < .001).
Conclusions: AMS programs are vital to improving antimicrobial use by clinicians. Understanding clini-
cians’ attitudes and perceptions related to AMS is important to ensure that AMS programs developed address
areas relevant to local clinical needs.
© 2017 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier
Inc. All rights reserved.
BACKGROUND
Antimicrobial resistance (AMR) is a major health care problem
worldwide with significant consequences.1 Patients with
antimicrobial-resistant infections are at greater risk of worse clin-
ical outcomes, recurrent infection, and death than infected patients
without AMR.2 As many as 25,000 people in Europe die every year
because of antibiotic-resistant microorganisms,3 and it is estimated
that >2 million people are infected by antibiotic-resistant patho-
gens resulting in 23,000 deaths annually in the United States.4 It has
been estimated that >500,000 people worldwide die every year as
a result of AMR.4 In Thailand, as many as 90,000 patients are af-
fected by AMR annually and the cost of the therapeutic use of
antibiotic medications is >$200million per year. The increase in AMR
has resulted in approximately 3.24 million extra days of hospital
stay and accounted for 38,481 deaths annually in Thailand.5 It is es-
timated that an additional 19,000 deaths are caused by multidrug-
resistant (MDR) bacteria in Thailand each year. Mortality attributed
to MDR was highest for hospital-acquired MDR Acinetobacter bac-
teremia (41%).6
Inappropriate use of antimicrobial medications is a major cause
of AMR. In U.S. hospitals, as many as 50% of antibiotics prescribed
are unnecessary or inappropriate,4 and 47% of antibiotic use in Aus-
tralian hospitals was found to be inconsistent with antimicrobial
guidelines or patients’ microbiologic results.7 Antimicrobial
* Address correspondence to Nantanit Sutthiruk, RN, MNS, School of Nursing and
Midwifery, Faculty of Health, Deakin University, Locked Bag 20000, Geelong, Victoria,
3220, Australia.
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stewardship (AMS) programs have been initiated to respond to the
growing problem of AMR. AMS is a process that aims to ensure
optimal antimicrobial medicine use and minimize AMR.8 For AMS
to be effective, hospital-wide AMS programs need the engage-
ment of multidisciplinary professionals who are involved in
antimicrobial prescribing and use.9 Clinicians need to be aware of
the causes and consequences of AMR and current evidence for ap-
propriate antimicrobial use.9,10 Differences and similarities between
professions will affect the implementation of AMS programs.9 Cli-
nician support for AMS programs has been identified in surveys
conducted in Europe,11 Australia,9 and the United States.12 However,
little is known about the attitudes and perceptions of clinicians
toward AMS in Thailand. The aim of this study was to explore the
perceptions and attitudes of clinicians. For the purpose of this study,
clinician refers to doctors, nurses, and pharmacists.
METHODS
This study was a cross-sectional survey of health professionals
at a 1,000-bed university hospital in Bangkok, Thailand. Data were
collected between November 9, 2015, and December 21, 2015. A
paper-based survey was distributed to 1,753 doctors, nurses, and
pharmacists in the following departments: surgery, pediatrics, med-
icine, operating room, pharmacy, obstetrics and gynecology,
orthopedics, ophthalmology, emergencymedicine, community health
nurses, family medicine, and anesthesiology. The overall response
rate was 62.0% (1,087/1,753). The specific response rates per pro-
fessional group were 41.4% (392/948) for doctors, 86.3% for nurses
(613/710), and 86.3% for pharmacists (82/95).
Survey instrument
The survey for this study was based on a survey used in an Aus-
tralian study.9 There were 26 items in the Australian survey of which
24 were retained: the 2 items deleted were related to Australian
guidelines and not relevant to the Thai context. Because antibiot-
ics can be purchased without prescription in Thailand and therefore
are widely used, 2 additional questions related to patient influ-
ences on antibiotic prescribing decisions and patients’ ability to buy
over-the-counter antibiotics were added by the researchers, because
these are important contextual issues for Thai health care.
To ensure content and face validity, the survey was reviewed by
the research team to determine that survey items were clear and
that survey content examined the correct concepts.13 The English
version was translated into Thai by 1 researcher. A nurse educator
from a Thai University who holds a PhD in Nursing (written in
English) performed a back translation from Thai to English. The con-
sistency of meaning between the Thai and the back-translated
English versions was determined by 1 researcher (N.S.). This com-
parison identified only minor differences that were corrected. The
content and face validity relevant to the Thai context and lan-
guage were established by a Thai panel consisting of specialists in
infection prevention and control. These specialists were infectious
disease physicians, an AMS specialist pharmacist, and a preven-
tion and control specialist nurse who evaluated the items for
relevance and accuracy. They independently rated the relevance of
each item to calculate a Content Validity Index. The Content Va-
lidity Index was 0.90. To ensure internal consistency, a pilot test of
the Thai version was conducted with 10 health care professionals
at the hospital before the study commenced, and coeﬃcient αwas
calculated as 0.89. Head nurses, senior doctors, and senior phar-
macists of each department and ward were asked to distribute the
survey to clinicians and remind them to complete the survey within
a 4-week period. The study was approved by the Human Research
Ethics Committees of Deakin University and the surveyed hospital.
Data analysis
Data were analyzed using SPSS version 23.0 for Windows (IBM,
Chicago, IL). Descriptive statistics (frequencies, percentages, means,
and SDs) were used to summarize the study data. Because the data
did not conform to the normal distribution, medians and first and
interquartile range are presented. For survey items that were cat-
egorical in nature, clinicians’ responses are presented as frequencies,
and comparisons were made using the χ2 test. For continuous data,
the Kruskal-Wallis test was used to compare the responses of dif-
ferent professional groups (doctors, nurses, and pharmacists).
RESULTS
A total of 1,087 clinicians completed the survey: 392 (36.1%) were
doctors, 613 (56.4%) were nurses, and 82 (7.5%) were pharmacists.
Overall, 80.9% (n = 879) of clinicians were women: 52.6% of doctors
(n = 206), 97.7% of nurses (n = 599), and 90.2% of pharmacists (n = 74).
Table 1 shows that clinicians were most commonly working in the
areas of surgery (20.8%), pediatrics (18%), and medicine (17.6%). The
median age was 29 years (interquartile range, 26-35), and ages
ranged from 22-70 years. Almost half the clinicians (42.3%) had
1-5 years of clinical experience (n = 460).
Clinician perceptions of AMR
Clinician perceptions in relation to AMR are presented in Table 2.
Comparedwith nurses, more doctors and pharmacists perceived that
patients’ ability to buy antibiotics over-the-counter was a signifi-
cant influence on AMR (P < .001). Clinicians, particularly doctors,
considered that AMRwas a serious problemworldwide, in Thai hos-
pitals, and at the surveyed hospital (P < .001). AMR in the Thai
community was considered less important, particularly by nurses
(P < .001). Clinicians, particularly doctors, believed that antimicro-
bial use in Thai hospitals contributed to AMR.
Clinicians’ responses toward AMS programs
Clinicians’ attitudes toward AMS programs are presented in
Table 3. Most clinicians from all professions agreed AMR would be
reduced by improving antimicrobial prescribing and it should be
a priority of the hospital and supported by a hospital-endorsed policy.
Clinicians perceived that local antimicrobial guidelines and proto-
cols, and a computer application to guide selection and duration
of antimicrobial therapy, would be clinically useful. However, doctors
were less likely than nurses and pharmacists to agree with a policy
that limits antimicrobial prescribing (P < .001). Doctors were also
less likely to be interested in participating in AMS education and
training than nurses and pharmacists (P < .001). Pharmacists were
more likely than doctors and nurses to agree that a team consist-
ing of an infectious disease specialist physician and pharmacist to
provide individualized antimicrobial prescribing advice and feed-
back would assist with antimicrobial selection (P < .001).
Previous involvement and experience with AMR and AMS
Clinicians’ responses to questions related to previous involve-
ment and experience with AMR and AMS are presented in Table 4.
Most clinicians had previously been involved in the care of pa-
tients with an antibiotic-resistant infection (88.1%). However, there
were less pharmacists involved in the care of patients with resis-
tant infections than doctors or nurses (59.8% vs 93.1% vs 88.7%,
respectively; P < .001). Most clinicians perceived increasing numbers
of antimicrobial-resistant infections over the last 5 years. Again, fewer
pharmacists perceived this change over time than doctors or nurses
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(P = .001). Overall, <1 in 5 clinicians (17.2%) had heard of AMS ter-
minology in English. Less than half the clinicians (37.6%) reported
that they had worked in health care facilities with AMS programs.
DISCUSSION
This study had 2 major findings. First, all clinicians surveyed per-
ceived AMR as a major problem, and that improved prescribing and
use of antibiotics was important. Second, there were differences
between professions regarding AMR and AMS that need to be con-
sidered when developing AMS programs for the Thai health care
system.
All clinicians surveyed perceived AMR as a major problem glob-
ally, in Thai hospitals, and at the surveyed hospital. The perception
that AMR is a major problem globally is reported in many other
studies.9-11,14-16 A few studies, including a study from Thailand, have
also found that clinicians perceived AMR as amajor problem for their
hospital.16,17 However, this is inconsistent, and several studies have
found that although clinicians may think AMR is a major problem,
they do not necessarily perceive AMR as a problem that affects
practice in their hospital.9-11,14-16 These findings are concerning
because AMR is an increasing and serious quality and safety issue.
Further, AMR is one of the biggest public health threats that re-
quires cooperation across government and public sectors globally
to prevent and control the spread of resistant infections.1,18 Resolv-
ing AMRwill be challenging if health care providers, oftenmistakenly,
do not perceive that AMR is an issue in their hospital so are not
willing to change their practice to address problems related to AMR.
The reason many health professionals are concerned about AMR
as a major issue in health care but not at their hospital is unclear.
One possible explanation may be the variation in availability of in-
fectious disease specialists in different hospitals. It may be proposed
that when infectious disease specialists are available for consulta-
tion, treating doctors may perceive less risk of AMR because they
are deferring decision-making to expert clinicians and expert judg-
ments about antibiotic use should limit the development of AMR.
Another possible reason for this finding is the different regulation
of purchasing and use of antibiotics in different countries. Antibi-
otics are purchased over-the-counter in many countries across the
world, including Thailand.10,19 Studies from Ethiopia and Peru where
Table 1
Clinicians’ employment characteristics
Demographic data All clinicians (N = 1,087) Doctors (n = 392) Nurses (n = 613) Pharmacists (n = 82)
Hospital departments
Surgery 226 (20.8) 76 (19.4) 150 (24.5) -
Pediatrics 196 (18.0) 51 (13.0) 145 (23.7) -
Medicine 191 (17.6) 115 (29.3) 76 (12.4) -
Operating room nurses 86 (7.9) - 86 (14.0) -
Pharmacy department 82 (7.5) - - 82 (100)
Obstetrics and gynecology 61 (5.6) 28 (7.1) 33 (5.4) -
Orthopedics 60 (5.5) 24 (6.1) 36 (5.9) -
Ophthalmology 51 (4.7) 24 (6.1) 27 (4.4) -
Emergency medicine 49 (4.5) 22 (5.6) 27 (4.4) -
Community health nurses 33 (3.0) - 33 (5.4) -
Family medicine 28 (2.6) 28 (7.1) - -
Anesthesiology 24 (2.2) 24 (6.1) - -
Years of experience since qualification
<1 94 (8.6) 2 (0.5) 76 (12.4) 16 (19.5)
1-5 460 (42.3) 171 (43.6) 252 (41.1) 37 (45.1)
6-10 247 (22.7) 122 (31.1) 107 (17.5) 18 (22)
11-20 204 (18.8) 61 (15.6) 135 (22) 8 (9.8)
>20 82 (7.5) 36 (9.2) 43 (7) 3 (3.7)
Age, y
Median 29 31 28 29
IQR 26-35 28-37 24-35 26-34
NOTE. Values are n (%) or as otherwise indicated.
IQR, interquartile range.
Table 2
Responses by profession to survey items related to antimicrobial resistance






(n = 82) χ2 df P value*
Indicate how serious a problem you believe antimicrobial resistance is in the following places†
Worldwide 7.0 (5.0-7.0) 7.0 (6.0-7.0) 6.0 (5.0-7.0) 6.0 (6.0-7.0) 61.53 2 <.001
Thai community 6.0 (4.0-7.0) 6.0 (5.0-7.0) 5.0 (4.0-6.0) 6.0 (5.0-7.0) 62.74 2 <.001
Thai hospitals 7.0 (6.0-7.0) 7.0 (6.0-7.0) 6.0 (5.0-7.0) 6.0 (6.0-7.0) 18.96 2 <.001
Surveyed hospital 7.0 (6.0-7.0) 7.0 (6.0-7.0) 6.0 (6.0-7.0) 6.0 (5.0-7.0) 38.34 2 <.001
Indicate how strongly you believe the following contribute to antimicrobial resistance at the surveyed hospital‡
Antimicrobial use in Thai animal and agricultural sectors 5.0 (4.0-5.0) 5.0 (4.0-6.0) 4.0 (3.0-5.0) 5.0 (4.0-6.0) 51.37 2 <.001
Antimicrobial use in Thai community 5.0 (4.0-6.0) 6.0 (5.0-7.0) 5.0 (4.0-6.0) 6.0 (5.0-6.0) 123.18 2 <.001
Antimicrobial use in Thai hospitals 6.0 (5.0-7.0) 6.0 (6.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-6.0) 85.01 2 <.001
Antimicrobial use at the surveyed hospital 6.0 (5.0-7.0) 6.0 (5.0-7.0) 5.0 (4.0-6.0) 5.0 (5.0-6.0) 52.48 2 <.001
Patient pressure for antibiotics as part of treatment 5.0 (4.0-6.0) 6.0 (5.0-7.0) 5.0 (3.0-6.0) 6.0 (5.0-6.0) 80.77 2 <.001
Patients are able to buy antibiotics over-the-counter 6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-6.0) 25.72 2 <.001
NOTE. Values are median (interquartile range) or as otherwise indicated.
*Kruskal-Wallis test.
†Rated on a Likert scale from 1 (not a problem) to 7 (very serious problem).
‡Rated on a Likert scale from 1 (does not contribute) to 7 (strongly contributes).
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people can buy antibiotics without a prescription also showed that
most clinicians agreed AMR is a serious problemworldwide but less
so in their own practice.10,15 These studies from countries where pre-
scriptions are not required to buy antibiotics may explain clinicians’
perceptions that AMR is a problem originating from outside their
hospital and from the broader community.
In Thailand, antibiotics are easily bought over-the-counter at
grocery stores or drug stores. Thai people commonly seek basic
advice from the pharmacist at a drug store if they are feeling unwell.19
Clinicians in our study reported that antibiotic use and patients’ pur-
chase of over-the-counter antibiotics were major influences on the
AMR problem. Most clinicians (88%) in this Thai study also re-
ported that caring for patients with an antibiotic-resistant infection
was common, which may explain perceptions of Thai clinicians that
AMR is a major issue in the surveyed hospital. However, the rela-
tionship between perceptions of AMR as amajor problem in hospitals
and having cared for patients with antibiotic-resistant infection is
not the same in all studies. An Australian study showed that al-
though 84% of the clinicians reported they cared for patients with
antibiotic resistance, only 45% of them reported AMR as a major
problem in their hospital.9
Most clinicians in this study agreed that systems for improved
antibiotic prescribing were important to reduce the occurrence of
AMR and should be a hospital priority. Many other studies have also
reported that systems to improve antibiotic prescribing would be
clinically useful to ensure the optimal prescribing and use of
antibiotics9,11,14-16,20 and support the premise that AMS programs de-
crease inappropriate antibiotic use, reduce health care costs, and
decrease the occurrence of AMR and adverse drug events, all of which
improve patient care.21 Therefore, the strategies and systems that
promote appropriate antibiotic use or AMS programs have been set
as a worldwide agenda.1 In 2011, the World Health Organization
launched the WHO Global Strategy on Containment of Antimicro-
bial Resistance campaign to empower every country in the world
to respond to the AMR problem.22
In many countries, systems for improved antibiotic prescribing
have been initiated as a national agenda. For example, in Austra-
lia, a hospital AMS strategy is one of the compulsory criteria for
approval of hospital accreditation.23 In the United States, the Infec-
tious Diseases Society of America published guidelines for improving
the use of antimicrobial agents in the hospital as far back as 1988.
Recently, in 2016, the U.S. National Action Plan for Combating
Antibiotic-Resistant Bacteria has been approved.18 In England, the
National Health Service has launched activities to support AMS since
1999 with regular updates of their national guidelines. Antimicro-
bial Stewardship Toolkit for English Hospitals was the most recent
AMS guideline to be published in August 2015.24 All these strate-
gies demonstrate that many countries across the world have
responded to the emergence of AMR as a major issue. AMS is rec-
ognized as a key strategy to improve the appropriateness of
antimicrobial use.21
There were a number of differences between professions in per-
ceptions of AMR. Nurses were less likely than doctors and
pharmacists to agree that AMR was a serious problem in the Thai
community, and that antibiotic use in the community contributed
to AMR at the surveyed hospital. One possible explanation was that
nurses surveyed in this studywere hospital nurses and rarely worked
in community settings. Therefore, their knowledge of AMR issues
Table 3









(n = 82) χ2 df P value*
Improving antimicrobial prescribing at the surveyed hospital
will help decrease antimicrobial resistance.
6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-6.25) 9.79 2 .008
Improving antimicrobial prescribing should be an
organizational priority.
6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-6.0) 1.17 2 .558
A formal policy for the use of antimicrobials should be
introduced at the surveyed hospital.
6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 1.38 2 .501
A policy that limits the prescribing of selected antimicrobials
to certain clinical indications via an approval process should
be introduced at the surveyed hospital.
6.0 (5.0-7.0) 5.0 (4.0-6.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 33.73 2 <.001
Local antimicrobial guidelines and protocols should be
introduced at the surveyed hospital.
6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 3.10 2 .212
A computer application which gives advice on selection and
duration of antimicrobial therapy for specific clinical
conditions would be clinically useful.
6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (6.0-7.0) 13.38 2 .001
A team consisting of an infectious disease specialist physician
and pharmacist providing individualized antimicrobial
prescribing advice and feedback would assist with
antimicrobial selection.
6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 7.0 (6.0-7.0) 18.05 2 <.001
I would be interested in participating in education sessions
about antimicrobial stewardship.
6.0 (5.0-7.0) 5.0 (4.0-6.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 22.45 2 <.001
I would be willing to participate in any activities to improve
the quality of antimicrobial use at the surveyed hospital.
6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (5.0-7.0) 6.0 (6.0-7.0) 16.08 2 <.001
NOTE. Values are median (interquartile range) or as otherwise indicated.
*Kruskal-Wallis test.
Table 4









(n = 82) χ2 df P value
Previously involved in care of patients with an antibiotic-resistant infection 958 (88.1) 365 (93.1) 554 (88.7) 49 (59.8) 79.52 4 <.001
Have noticed increasing number of antimicrobial-resistant infections over last 5 y 895 (82.3) 335 (85.5) 504 (82.2) 56 (68.3) 18.58 4 .001
Have heard of term antimicrobial stewardship (English term) 187 (17.2) 80 (20.4) 67 (10.9) 40 (48.8) 99.49 4 <.001
Worked in health care facilities with antimicrobial stewardship programs 409 (37.6) 154 (39.3) 217 (35.4) 38 (46.3) 42.16 4 <.001
NOTE. Values are n (%) or as otherwise indicated.
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in the community may be poor. Although both nurses and doctors
take a health history that includes antibiotic use in the communi-
ty, doctors have the major responsibility for prescribing so are more
likely than nurses to consider antibiotic use in the community in
their decision-making. Doctors also consult pharmacists for advice
regarding antibiotic prescriptions; therefore, pharmacists may also
have a deeper understanding than nurses of the consequences of
antibiotic use in the community. The finding that nurses were less
concerned than doctors and pharmacists about AMR in the com-
munity is similar to the results of an Australian study that showed
nurses, doctors, and pharmacists believed that antibiotic use in the
Australian community contributed to AMR at their hospital by 38%,
57%, and 70%, respectively.9
Nurses were more likely than pharmacists to report being in-
volved in the care of patients with antibiotic resistance and less likely
to report that patient pressure to prescribe antibiotics contributes
to AMR. AMR is an important consideration when providing edu-
cation to nurses about antibiotic use because nurses have a major
role in antibiotic management during a patient’s hospitalization.
Further, nurses have the most direct contact with patients and fami-
lies; therefore, it is vital that nurses provide patient and family
education about antibiotics throughout their hospital stay and prior
to discharge from hospital.25
Despite doctors agreeing that guidelines and protocols to support
antibiotic prescribing would be useful, doctors were significantly
less likely than nurses and pharmacists to agree with any inter-
ventions that limit prescribing decisions. The finding that doctors
do not favor interventions that limit prescribing has also been
reflected in other studies.9 Previous studies show that doctors are
one of the most trusted professions and have high levels of
decision-making about patient care.26 Therefore, doctors may
not see a need to change their practice or a need to be involved
in AMS programs. AMR is a worldwide problem that will require
multidisciplinary solutions. Involving doctors in the design
of AMS programs and engaging them to critically examine their
antibiotic prescribing may be needed along with audit and restric-
tive activities.
Pharmacists seemed to have a higher focus on system improve-
ments than doctors and nurses. Other studies from Australia also
show that pharmacists seemed to be more engaged with AMS
systems than doctors and nurses.9 One possible reason for this dif-
ference in perceptions of systems to improve AMS may be that
pharmacists have more of an overview of the whole hospital,
whereas doctors and nurses only know the patients and practices
on their ward or wards. In the surveyed hospital, it is general prac-
tice for pharmacists to work across the whole hospital, whereas
nurses typically only work in 1 ward and doctors may visit 2 or 3
wards. It is probable that these working circumstances of pharma-
cists, doctors, and nurses are similar in other countries.
There are a number of limitations that should be consideredwhen
interpreting the study findings. First, the study was conducted at
a single site that was a well-resourced university hospital in Thai-
land. Therefore, the study results may not be generalizable to other
Thai hospitals, particularly smaller rural hospitals. Second, partici-
pants were self-selecting and the characteristics of those who did
not participate in the survey are unknown. Further, purposive sam-
pling was used to target doctors, nurses, and pharmacists from
departments with high antibiotic use; therefore, there are depart-
ments such as psychiatry that are underrepresented. It is therefore
possible that the sampling approach and recruitment limit the
generalizability of the study results to other departments or hos-
pitals. Despite the sampling limitations, 1,087 clinicians participated
in the survey and the overall response rate was 62%; therefore, there
is confidence that the study results represent those groups tar-
geted for inclusion.
CONCLUSIONS
This study is the first large-scale survey of doctors, nurses, and
pharmacists regarding AMR and AMS in Thailand. The staff survey
was based on a survey used in an Australian study to understand
clinicians’ perceptions and attitudes toward AMR and AMS in the
Thai health care context. The major findings were that all partici-
pants surveyed perceived AMR as a major problem and that
improved prescribing and use of antibiotics was important. Further,
there were differences between professions regarding AMR and AMS.
The results of this study highlight the potential barriers and facili-
tators to effective implementation of AMS programs in Thai hospitals.
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